top of page

A unique and adaptive drug delivery platform that combines Cold Atmospheric Plasma (CAP) with biodegradable and synthetic biomaterials pre-loaded with drugs to deliver and potentiate their effect
-
CAP, an electrically excited, partially ionised gas containing a cocktail of biologically important molecules, is used to trigger release of drugs incorporated within novel biomaterials.
-
Co-delivery of drug with CAP enhances drug efficacy, is site-specific and on-demand, with potentially reduced doses.
-
Offers an effective alternative to oral and intravenous delivery that is simple and painless and can be tailored for both external and internal sites.
-
Particularly useful where either current drugs are ineffective or where resistance has developed, such as with certain chemotherapeutics.
Increased potency
CAP + drug potentiates effect of drug
Versatile
Compatible with a range of active pharmaceutical agents
Effective
Delivery across (skin) barrier and deep into tissues
Precise
Targeted, controlled and on-demand
bottom of page